Ravi Iyer has been appointed Associate Director – Market Research, Business Insights and Analytics at Eli Lilly and Company, marking a significant step forward in his career in healthcare analytics and market intelligence.

Ravi joined Eli Lilly in 2024 as a Consultant – Market Research and subsequently progressed to Senior Consultant, demonstrating strong expertise in analytics-driven insights and strategic market understanding before stepping into his current leadership role.

Prior to joining Eli Lilly, he spent nearly five years at Novartis, where he advanced from Senior Analyst – Insights & Analytics to Manager – Insights & Analytics, contributing to data-driven strategies and market intelligence initiatives supporting pharmaceutical business operations.

Earlier in his career, Ravi built a strong foundation in research and analytics at Grail Insights (now Escalent), where he worked on market research and business intelligence projects across sectors.

CXO TechBOT wishes Ravi Iyer great success in his new role.